IE 11 is not supported. For an optimal experience visit our site on another browser.

Could full FDA approval of Pfizer Covid vaccine boost nationwide vaccination rate?


Professor and physician at Georgetown University and former Chief Scientist at the FDA, Dr. Jesse Goodman, explains the difference between emergency use authorization and full approval of Pfizer’s Covid-19 vaccine and whether full authorization could impact vaccine rates across the country.